BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld
Home
» C4 lines up Roche, Biogen for $1.3B+ in discovery deals
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
C4 lines up Roche, Biogen for $1.3B+ in discovery deals
Jan. 7, 2019
By
Brian Orelli
No Comments
Living up to its name, C4 Therapeutics Inc. exploded onto the scene before the J.P Morgan Healthcare conference in 2016 with a $73 million series A and a Roche Holding AG deal worth more than $750 million in hand. (See BioWorld Today, Jan. 7, 2016.)
BioWorld